Tirzepatide is an FDA-approved weekly injection used to treat type 2 diabetes. Although its primary purpose is for diabetes management, doctors may prescribe it off-label for weight loss. Clinical trials have demonstrated that tirzepatide can aid in weight loss, despite lacking FDA approval specifically for this purpose. At EllieMD, our healthcare providers may prescribe a customized version of tirzepatide, potentially containing additional metabolic support ingredients. The pharmacy that ships your medication will depend on your state of residence, and each partnered pharmacy may offer its unique blend of metabolic support ingredients. As a result, you may receive different metabolic support ingredients based on your location.

When purchasing a weight management product, you are committing to a 3-month subscription plan which cannot be canceled. After 3 months, you can continue your weight management journey on another 3-month plan on the same or higher dosage depending on your medical provider's advice.

Tirzepatide aids in weight loss by reducing hunger and increasing the feeling of fullness. It mimics the effects of natural hormones in your body, GLP-1 and GIP, which regulate appetite and blood sugar levels. Additionally, the medication slows down the emptying of your stomach, helping you feel satisfied sooner and remain full for an extended period.

EllieMD compounds semaglutide and tirzepatide with Vitamin B12 (cyanocobalamin). This metabolic support ingredient is added to enhance the overall benefits of the treatment. Vitamin B12 plays a critical role in energy metabolism and supports patients’ overall health, making the compounded formulation unique compared to commercially available options. These compounds are prepared in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act to address specific patient needs and provide personalized care solutions.

EllieMD partners with a pharmacy that operates in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act. This ensures compliance in preparing customized formulations with pharmaceutical-grade ingredients, such as semaglutide and tirzepatide with Vitamin B12, to meet personalized care standards.

Tirzepatide is generally safe when used as prescribed and monitored by a healthcare provider. However, like any medication, it can cause side effects. Common side effects of tirzepatide include nausea, vomiting, diarrhea, and constipation. These side effects are usually mild and resolve over time. In rare cases, more serious side effects like severe stomach or kidney problems may occur. It’s important to discuss the potential risks and benefits of tirzepatide with your healthcare provider and to promptly report any side effects or concerns you may have.

Semaglutide is a medication approved by the FDA for treating type 2 diabetes and helping with long-term weight management. Tirzepatide is also FDA-approved for type 2 diabetes treatment. While it’s mainly used for diabetes, doctors may sometimes prescribe tirzepatide 'off-label' to help with weight loss. Even though it hasn’t been officially approved for this purpose by the FDA, studies have shown that tirzepatide can help people lose weight. Both semaglutide and tirzepatide are part of a group of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). They work by acting like a hormone called GLP-1, which helps control blood sugar levels. Tirzepatide goes a step further by also mimicking another hormone called glucose-dependent insulinotropic polypeptide (GIP). Research has found that the combined effect of GLP-1 and GIP in tirzepatide is more effective for weight loss compared to semaglutide.

The package will include a vial of the medication (sufficient for up to 12 weeks, subject to your location and chosen pharmacy), instructional materials (with web links to video content), insulin needles, and alcohol swabs.

Eligibility includes being 18 or older, residing in a state where EllieMD services are available, and meeting FDA-approved criteria (BMI >30 or >27 with qualifying health conditions). Certain medical conditions, such as type 1 diabetes or recent bariatric surgery, may disqualify eligibility.

Avoid using these medications if you have a history of medullary thyroid carcinoma, MEN-2, or pancreatitis. Pregnant individuals and those with recent bariatric surgery or specific allergies should also consult a healthcare provider before use.